GeneDx Holdings Corp. (WGS)
↓ Download CSV- Sector Services
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, GeneDx Holdings Corp. reported revenue of $427.54M, up 40.0% from the prior year. The company ran a net loss, with a net margin of -4.9% and a gross margin of 69.7%. It held $523.71M in total assets against $215.53M in total liabilities.
Key ratios (FY2025)
69.7%
Gross margin
-3.1%
Operating margin
-4.9%
Net margin
-6.8%
Return on equity
+40.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $427.54M | $305.45M | $202.57M | $234.69M | $212.19M | $179.32M | $196.17M | — |
| Cost of Revenue | $129.37M | $111.05M | $112.56M | $261.44M | $228.80M | $175.30M | $113.39M | — |
| Gross Profit | $298.17M | $194.40M | $90.01M | -$26.75M | -$16.60M | $4.03M | $82.78M | — |
| Operating Income | -$13.08M | -$23.21M | -$180.60M | -$667.65M | -$446.15M | -$241.99M | -$30.41M | — |
| Net Income | -$21.02M | -$52.29M | -$175.77M | -$548.98M | -$245.39M | -$241.34M | -$29.70M | — |
| EPS (Diluted) | $-0.73 | $-1.94 | $-7.23 | $-53.63 | $-2.27 | $-47036.00 | $-264056.00 | — |
| Total Assets | $523.71M | $419.38M | $418.76M | $490.94M | $554.09M | $251.64M | — | — |
| Total Liabilities | $215.53M | $174.13M | $190.74M | $237.24M | $165.99M | $247.25M | — | — |
| Shareholders' Equity | $308.18M | $245.25M | $228.02M | $253.71M | $388.10M | -$330.05M | -$88.71M | -$55.97M |
| Cash & Equivalents | $105.00M | $85.21M | $99.68M | $123.93M | $400.57M | $108.13M | — | — |
| Operating Cash Flow | $33.28M | -$28.50M | -$180.15M | -$319.15M | -$190.43M | -$93.13M | -$18.73M | — |
| Capital Expenditures | $19.02M | $5.49M | $5.25M | $7.16M | $9.40M | $24.09M | $11.92M | — |
| Shares Outstanding | 28.64M | 26.89M | 24.31M | 10.24M | 108.08M | 5.1K | 124 | — |